MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-DL-06-0010556
Vipul Pharma Private Limited
Vipul Pharma Private Limited - pharma in Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹5.95 Cr
▼ 30% YoY
Net profit · FY 2025
₹2.74 Lakh
Net margin 0.5%
EBITDA · FY 2025
₹13.06 Lakh
EBITDA margin 2.2%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹3 Cr
Satisfied ₹6.5 Cr
Company age
17 yrs
Est. 2009
Directors on board
2
As per MCA filings
About Vipul Pharma Private Limited
Data last updated:
Vipul Pharma Private Limited is a private limited company based in Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 16 December 2009 and has been in existence for over 17 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24232DL2009PTC196994. Its GSTIN is 07AADCV1457C1ZL (Delhi). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Sonia Kansal (Whole-Time Director) and Parvinder Kansal (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Unit No.805 Klj Tower Netaji Subhash Place Pitampura, Delhi, India – 110034.
As per the financials filed for FY 2025, the company reported a revenue of ₹5.95 Cr, a decline of 30% compared to the previous year. For the same year it recorded a net profit of ₹2.74 Lakh (net margin 0.5%) and EBITDA of ₹13.06 Lakh (EBITDA margin 2.2%). Revenue has declined at a compounded annual rate (CAGR) of 25% over three years and 17% over five years.
As per MCA filings, the company has open charges of ₹3 Cr and satisfied charges of ₹6.5 Cr on record. Court records list 10 cases involving the company, including 10 filed by the company; 10 cases are pending.
Vipul Pharma Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-06-0010556). The current compliance status is marked as compliant by the Registrar of Companies.
Company Details of Vipul Pharma Private Limited
CIN U24232DL2009PTC196994
Registration Number 196994
Incorporation Date 16 December 2009
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-DL-06-0010556
Recognitions & Rankings of Vipul Pharma
Contact Details
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressUnit No.805 Klj Tower Netaji Subhash Place Pitampura, Delhi, India – 110034
- IndustryPharma, Drug Formulation & Development
Comprehensive company report
Vipul Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business Activity of Vipul Pharma Private Limited
The main business activity of Vipul Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Vipul Pharma Private Limited FY 2025 filings available
Vipul Pharma Private Limited reported revenue of ₹5.95 Cr (down 30% YoY) for FY 2025.
Revenue · FY 2025
₹5.95 Cr ▼ 30%
Net profit · FY 2025
₹2.74 Lakh margin 0.5%
EBITDA · FY 2025
₹13.06 Lakh margin 2.2%
Compounded Annual Growth Rate (CAGR) of Vipul Pharma Private Limited
Revenue CAGR growth
1 year
▼ 30%
3 years · compounded
▼ 25%
5 years · compounded
▼ 17%
EBITDA CAGR growth
1 year
▼ 37%
3 years · compounded
▼ 19%
5 years · compounded
▼ 13%
Revenue has declined at a compounded annual rate (CAGR) of 17% over five years, including a 30% fall in the latest year. EBITDA fell 37% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Vipul Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹13.06 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹2.74 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Vipul Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.2% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 0.5% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Vipul Pharma are in the company report.
Premium access
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Vipul Pharma Private Limited
Vipul Pharma has 2 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sonia Kansal | Whole-Time Director | 08 Aug 2017 | 9 Years 2 Months | Current |
| Parvinder Kansal | Whole-Time Director | 16 Dec 2009 | 16 Years 10 Months | Current |
Peer Comparison of Vipul Pharma Private Limited
Vipul Pharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Corona Pharmaceuticals Private Limited. | ₹6.01 Cr (FY 2025) | •••• | •••• | 5.0% | •••• | Kashipur, Uttarakhand, India |
| Marion Biotech Private Limited | ₹6 Cr (FY 2025) | •••• | •••• | -39.0% | •••• | New Delhi, Delhi, India |
| Ila Biomarine Private Limited | ₹5.99 Cr (FY 2025) | •••• | •••• | 13.0% | •••• | Mumbai, Maharashtra, India |
| Crenza Pharmaceuticals Private Limited | ₹5.97 Cr (FY 2025) | •••• | •••• | 3.0% | •••• | Hyderabad, Telangana, India |
| Eden Health Care Private Limited | ₹5.96 Cr (FY 2025) | •••• | •••• | 11.0% | •••• | Ahmedabad, Gujarat, India |
| Vipul Pharma Private Limited this company | ₹5.95 Cr (FY 2025) | •••• | •••• | -30.0% | •••• | Delhi, India |
| Ardmore Healthcare Private Limited | ₹5.94 Cr (FY 2025) | •••• | •••• | 6.0% | •••• | Mumbai, Maharashtra, India |
| B. Sharda Pharma-Chem Limited | ₹5.93 Cr (FY 2024) | •••• | •••• | -10.0% | •••• | Gujarat, India |
| Scotmed Care Private Limited | ₹5.93 Cr (FY 2025) | •••• | •••• | -4.0% | •••• | Jagadhari, Haryana, India |
| Leogenic Healthcare Private Limited | ₹5.93 Cr (FY 2020) | •••• | •••• | 4239.0% | •••• | Mumbai, Maharashtra, India |
| Sia Pharma Private Limited | ₹5.92 Cr (FY 2024) | •••• | •••• | -53.0% | •••• | Ganaur, Haryana, India |
Peers are the five companies nearest above and the five nearest below Vipul Pharma by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Vipul Pharma Private Limited
Vipul Pharma Private Limited is audited by SAMARATH M SURANA & CO for the financial year 2021.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| SAMARATH M SURANA & CO | Locked | Locked | Locked |
Premium access
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Vipul Pharma Private Limited
Premium access
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Vipul Pharma Private Limited
Open charges
₹3 Cr
Satisfied charges
₹6.5 Cr
Breakdown by lending institutions
Latest charge details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 07 Aug 2020 | Others | ₹3 Cr | Open |
| 05 Nov 2018 | Hdfc Bank Limited | ₹2 Cr | Satisfied |
| 20 Apr 2017 | Yes Bank Limited | ₹3 Cr | Satisfied |
| 21 Jul 2016 | Indian Bank | ₹1.5 Cr | Satisfied |
Total charge records: 4 View all charges
Legal Cases of Vipul Pharma Private Limited
Vipul Pharma Private Limited has 10 court cases on record: 10 filed by Vipul Pharma. All cases are pending. Status as checked on 21 Sep 2026.
Total cases
10
Filed by the company
10
Pending
10
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 10 | 0 | 10 |
Cases on record (1 of 10)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, South West, Delhi | Cheque dishonour complaint | Filed by the company against Ukar Healthcare Private Limited | Pending |
Premium access
Full case history
All 10 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Vipul Pharma Private Limited
Employment history and EPFO contributions of people linked to Vipul Pharma.
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Vipul Pharma Private Limited
Vipul Pharma Private Limited has 8 board changes on record since 2009: 2 appointments and 6 cessations. The latest: Parvinder Kansal ceased to be Director on 28 Sep 2017.
AGM
Vipul Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Vipul Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi Ii.
Charges
A charge with Others amounted to Rs. 300.00 Lakh with Charge ID 100359253 was registered on 07 Aug 2020.
Charges
A charge registered on 20 Apr 2017 via Charge ID 100132022 with Yes Bank Limited was fully satisfied on 11 Jun 2020.
Charges
A charge registered on 05 Nov 2018 via Charge ID 100220944 with Hdfc Bank Limited was fully satisfied on 12 Feb 2020.
Charges
A charge with Yes Bank Limited of Rs. 300.00 Lakh registered on 20 Apr 2017 with Charge ID 100132022 was modified on 16 Feb 2019.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 200.00 Lakh with Charge ID 100220944 was registered on 05 Nov 2018.
Charges
A charge registered on 21 Jul 2016 via Charge ID 100042976 with Indian Bank was fully satisfied on 08 Dec 2017.
Ceased
Parvinder Kansal ceased to be Director.
Ceased
Sonia Kansal ceased to be Additional Director.
Ceased
Ankur Mangla ceased to be Whole-Time Director.
Appointed
Sonia Kansal was appointed as Whole-Time Director.
7 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Vipul Pharma Private Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Vipul Pharma Private Limited
Premium access
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Vipul Pharma Private Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Vipul Pharma Private Limited
Vipul Pharma has 2 GST registrations: 2 active.
Total GSTINs
2
Active
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AADCV1457C1ZL | Delhi | Active | 01 Jul 2017 |
| 04AADCV1457C1ZR | Chandigarh | Active | 01 Jul 2017 |
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Vipul Pharma Private Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Vipul Pharma Private Limited
Vipul Pharma is an active private limited company based in Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 16 December 2009 (17+ years old) and is registered under CIN U24232DL2009PTC196994.
Vipul Pharma reported revenue of ₹5.95 Cr for FY 2025 (down 30% YoY).
Vipul Pharma has 2 current directors:
- Sonia Kansal - Whole-Time Director
- Parvinder Kansal - Whole-Time Director
Vipul Pharma reported a net profit of ₹2.74 Lakh (net margin 0.5%) and EBITDA of ₹13.06 Lakh (EBITDA margin 2.2%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Vipul Pharma is -25% over three years and -17% over five years. In the latest year (FY 2025) revenue fell 30%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Vipul Pharma is 07AADCV1457C1ZL, registered in Delhi. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 04AADCV1457C1ZR (Chandigarh).
The CIN (Corporate Identification Number) of Vipul Pharma is U24232DL2009PTC196994. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Vipul Pharma has 10 court cases on record: 10 filed by the company. 10 are pending.
Vipul Pharma was incorporated on 16 December 2009, making it 17+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Vipul Pharma by revenue are Corona Pharmaceuticals Private Limited, Marion Biotech Private Limited, Ila Biomarine Private Limited, Crenza Pharmaceuticals Private Limited, Eden Health Care Private Limited and 5 more, all in the Pharma industry (Formulations).
Parvinder Kansal ceased to be Director on 28 Sep 2017. Sonia Kansal ceased to be Additional Director on 28 Sep 2017. Ankur Mangla ceased to be Whole-Time Director on 21 Sep 2017. Vipul Pharma has 8 board changes on record in total.